Zobrazeno 1 - 10
of 343
pro vyhledávání: '"Jonathan Kay"'
Autor:
Ran Jin, Silvia Kruppert, Florian Scholz, Isabelle Bardoulat, Khalil Karzazi, Francois Morand, Greg Kricorian, David Collier, Jonathan Kay
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 523-537 (2024)
Abstract Introduction ABP 501 was an adalimumab (ADA) biosimilar approved for treating immune-mediated inflammatory diseases (IMIDs) including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). In this retrospectiv
Externí odkaz:
https://doaj.org/article/178d418368b84090a9c3cdba7e8d6b95
Autor:
Sofia Ramiro, Atul Deodhar, Philip J Mease, Martin Rudwaleit, Jonathan Kay, Marina Magrey, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Michael F Mørup, Christine de la Loge
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective To assess how achievement of increasingly stringent clinical response criteria and disease activity states at week 52 translate into changes in core domains in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthrit
Externí odkaz:
https://doaj.org/article/b0bf5a183aca4f3db52fc23fd3c2cd26
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 11, Iss 1 (2024)
**Background:** Medication formularies, initially designed to promote the use of cost-effective generic drugs, are now designed to maximize financial benefits for the pharmacy benefit management companies that negotiate purchase prices. In the second
Externí odkaz:
https://doaj.org/article/a68a15f619a2411a87310803bec5a81b
Autor:
Claudia Buhigas, Anne Y. Warren, Wing-Kit Leung, Hayley C. Whitaker, Hayley J. Luxton, Steve Hawkins, Jonathan Kay, Adam Butler, Yaobo Xu, Dan J. Woodcock, Sue Merson, Fiona M. Frame, Atef Sahli, Federico Abascal, CRUK-ICGC Prostate Cancer Group, Iñigo Martincorena, G. Steven Bova, Christopher S. Foster, Peter Campbell, Norman J. Maitland, David E. Neal, Charlie E. Massie, Andy G. Lynch, Rosalind A. Eeles, Colin S. Cooper, David C. Wedge, Daniel S. Brewer
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-16 (2022)
Abstract Background Up to 80% of cases of prostate cancer present with multifocal independent tumour lesions leading to the concept of a field effect present in the normal prostate predisposing to cancer development. In the present study we applied W
Externí odkaz:
https://doaj.org/article/ab88a2ce376d486096a3008701e9592f
Autor:
Kate L. Lapane, Catherine Dubé, Katarina Ferrucci, Sara Khan, Kristine A. Kuhn, Esther Yi, Jonathan Kay, Shao-Hsien Liu
Publikováno v:
BMC Family Practice, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background The average time to a diagnosis for people with axial spondyloarthritis (axSpA) is 7-10 years. Delayed diagnosis may result in increased structural damage, worse physical function, and worse quality of life relative to patients wi
Externí odkaz:
https://doaj.org/article/3aecc9798dd24fa6b8e99ba0bbb46b02
Autor:
Jonathan Kay, Kate L Lapane, Divya Shridharmurthy, Jonggyu Baek, Anthony Nunes, Shao-Hsien Liu
Publikováno v:
BMJ Open, Vol 12, Iss 12 (2022)
Objectives To evaluate comanagement with rheumatology and biological prescriptions filled during pregnancy among women with axial spondyloarthritis (axSpA), rheumatoid arthritis (RA) or psoriatic arthritis (PsA) and to examine factors associated with
Externí odkaz:
https://doaj.org/article/bf72353ed5fe4d2590a94c7ee0cc4897
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives This exploratory analysis investigated the potential use of the multibiomarker disease activity (MBDA) score to support biosimilarity assessments using data from two randomised controlled trials (RCTs) of biosimilar infliximab (IFX-qbtx) a
Externí odkaz:
https://doaj.org/article/47d8bc8df4e64e589a693cd1f20f04d6
Autor:
Kyung‐Sang Yu, In‐Jin Jang, Hyeong‐Seok Lim, Jang Hee Hong, Min‐Gul Kim, Min Kyu Park, Doo‐Yeoun Cho, Min Soo Park, Jae Yong Chung, Jong‐Lyul Ghim, SeungHwan Lee, Seok Kyu Yoon, In Sun Kwon, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Jung Bin Cha, Daniel E. Furst, Edward Keystone, Jonathan Kay
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 4, Pp 1280-1291 (2021)
Abstract This study aimed to demonstrate pharmacokinetic (PK) equivalence of a single dose of the proposed adalimumab biosimilar CT‐P17 to United States‐licensed adalimumab (US‐adalimumab) and European Union‐approved adalimumab (EU‐adalimum
Externí odkaz:
https://doaj.org/article/7d507bd001904a1aa34884f6d604a326
Autor:
Jonathan Kay, Janusz Jaworski, Rafal Wojciechowski, Piotr Wiland, Anna Dudek, Marek Krogulec, Slawomir Jeka, Agnieszka Zielinska, Jakub Trefler, Katarzyna Bartnicka-Maslowska, Magdalena Krajewska-Wlodarczyk, Piotr A. Klimiuk, Sang Joon Lee, Yun Ju Bae, Go Eun Yang, Jae Kyoung Yoo, Daniel E. Furst, Edward Keystone
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Abstract Background To demonstrate equivalent efficacy of the proposed high-concentration (100 mg/ml), citrate-free adalimumab biosimilar CT-P17 to European Union-approved adalimumab (EU-adalimumab) in subjects with active rheumatoid arthritis (RA).
Externí odkaz:
https://doaj.org/article/6b49e98734e7429687859127a57bc3fa
Autor:
Divya Shridharmurthy, Kate L Lapane, Sara Khan, Esther Yi, Jonggyu Baek, Jonathan Kay, Shao-Hsien Liu
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0269494 (2022)
BackgroundPeople with axial Spondyloarthritis (axSpA) suffer from lengthy diagnostic delays of ~7 years. The usage of screening tools to identify axSpA patients in primary care can reduce diagnostic delays by facilitating early referral to rheumatolo
Externí odkaz:
https://doaj.org/article/b9b7b98f95e74291810a9047cecb509a